Evaluation of immune response to single dose of quadrivalent HPV vaccine at 10-year post-vaccination

Smita Joshi, Devasena Anantharaman, Richard Muwonge, Neerja Bhatla, Gitika Panicker, Julia Butt, Usha Rani Reddy Poli, Sylla G. Malvi, Pulikkottil O. Esmy, Eric Lucas, Yogesh Verma, Anand Shah, Eric Zomawia, Sharmila Pimple, Kasturi Jayant, Sanjay Hingmire, Aruna Chiwate, Uma Divate, Shachi Vashist, Gauravi Mishra, Radhika Jadhav, Maqsood Siddiqi, Subha Sankaran, Thiraviam Pillai Rameshwari Ammal Kannan, Purnima Kartha, Surendra S. Shastri, Catherine Sauvaget, M. Radhakrishna Pillai, Tim Waterboer, Martin Müller, Peter Seh, Elizabeth R. Unger, Rengaswamy Sankaranarayanan, Partha Basu(2023)

Impact of HPV vaccination on HPV-related oral infections.

Tarik Gheit, Richard Muwonge, Eric Lucas, Luisa Galati,Devasena Anantharaman, M. Radhakrishna Pillai, Partha Basu , Rengaswamy Sankaranarayanan, Massimo Tommasino. (2023)

The IARC Perspective on Oral Cancer Prevention.

Véronique Bouvard, Suzanne T. Nethan, Deependra Singh, Saman Warnakulasuriya, Ravi Mehrotra, Anil Chaturvedi, Tony Hsiu-Hsi Chen, Olalekan A. Ayo-Yusuf, Prakash C. Gupta, Alexander Ross Kerr, Wanninayake M. Tilakaratne, Devasena Anantharaman , David I. Conway, Ann Gillenwater, Newell W Johnson, Luiz P. Kowalski, Maria Elena Leon, Olena Mandrik, Toru Nagao, Vinayak M. Prasad, Kunnambath Ramadas, Felipe Roitberg, Pierre Saintigny, Rengaswamy Sankaranarayanan, Alan Roger Santos-Silva,Dhirendra Sinha, Patravoot Vatanasapt, Rosnah B. Zain,Béatrice Lauby-Secretan. (2023)

Accuracy of high-risk HPV DNA PCR p16(INK4a) immunohistochemistry or the combination of both to diagnose HPV-driven oropharyngeal cancer.

Simoens C, Gheit T, Ridder R, Gorbaslieva I, Holzinger D, Lucas E, Rehm S, Vermeulen P, Lammens M, Vanderveken OM, Kumar RV, Gangane N, Caniglia A, Maffini F, Rubio MBL, Anantharaman D, Chiocca S, Brennan P, Pillai MR, Sankaranarayanan R, Bogers J, Pawlita M, Tommasino M, Arbyn M HPV-AHEAD study group. (2022)

Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one two and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study

Basu P, Malvi SG, Joshi S, Bhatla N, Muwonge R, Lucas E, Verma Y, Esmy PO, Poli URR, Shah A, Zomawia E, Pimple S, Jayant K, Hingmire S, Chiwate A, Divate U, Vashist S, Mishra G, Jadhav R, Siddiqi M, Sankaran S, Prabhu PR, Kannan TPRA, Varghese R, Shastri SS, Anantharaman D, Gheit T, Tommasino M, Sauvaget C, Pillai MR, Sankaranarayanan R. (2022)